-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下：我们将MPWR的12个月目标股价从1500美元上调至1600美元，市盈率约为2027年每股收益的58倍，高于同行，以反映我们对该公司强劲增长的预期。在MPWR发布了优于预期的第一季度和第二季度业绩指引后，我们将2026年每股收益预期上调至24.66美元（22.40美元），2027年每股收益预期上调至27.54美元（26.68美元）。MPWR的优异表现得益于其强大的执行力和多元化的市场战略，尤其是在通信和企业数据领域，其增长势头强劲。MPWR将今年企业数据领域的增长预期从50%的下限上调至85%，表明其对人工智能和服务器市场前景更加清晰。该公司还宣布计划将其制造能力从40亿美元扩大至60亿美元，以支持未来的增长，我们预计这将推动未来两到三年的业绩上涨。通信业务板块表现亮眼，环比增长33%，这主要得益于光模块和交换机电源解决方案的强劲销售。尽管我们对该板块前景持乐观态度，但我们认为其过高的估值已经未能充分反映这一增长。
Related Articles
Asia
National Australia Bank Posts Fiscal H1 Cash EPS of AU$0.861, Net Operating Income of AU$10.87 Billion
$ASX:NAB
Asia
Air New Zealand Group Capacity Rises in March
Air New Zealand (ASX:AIZ, NZE:AIR) group capacity rose 4.1% year on year in March, according to a Monday filing with the Australian and New Zealand bourses.Long-haul available seat kilometers (ASKs) rose 2.5%, while domestic ASKs increased by 3.4%, per the filing.Short-haul international ASKs rose 7.6% year on year, supported by the addition of two new A321 aircraft.Group year-to-date underlying revenue per available seat kilometer rose 2.7% from the prior year.The airline carried 1.6 million passengers in March, about the same as the previous year, while the passenger load factor rose to nearly 86%, up from around 83%, the filing added.
$ASX:AIZ$NZE:AIR
Asia
a2 Milk Co. Recalls US Infant Formula Batches After Toxin Detection
a2 Milk Co. (ASX:A2M, NZE:ATM) started a voluntary recall on May 1 of three batches of its a2 Platinum USA infant milk formula, following the detection of cereulide in product manufactured by Synlait Milk (ASX:SM1, NZE:SML), according to separate Monday filings with the Australian and New Zealand bourses.The product was sold only in the US via online platforms and select retailers and had already been discontinued before the recall, while all a2 Platinum products sold outside the US remain unaffected, per the filing.No illnesses have been reported, and any symptoms are typically mild and short-lived, a2 Milk said, adding that it is working with the US Food and Drug Administration and has provided guidance to US consumers who may have purchased the product.The recall reflects updated guidance from New Zealand authorities on managing cereulide risks, a2 Milk said.The companies said they do not expect the recall to impact their financial results.
$ASX:A2M$ASX:SM1$NZE:ATM$NZE:SML